Further, SYT8 is a candidate biomarker specific for peritoneal metastasis, according to the results of a recurrence pattern‐specific transcriptome analysis of patients with stage III GC who underwent curative gastrectomy and adjuvant S‐1 monotherapy 24. Here, SYT8 is linked to gastric cancer.